Inspire Medical Systems Narrows FY2026 Adj EPS Guidance from $1.05-$1.45 to $1.20-$1.40 vs $1.25 Est; Narrows FY2026 Sales Guidance from $835.000M-$875.000M to $850.000M-$860.000M vs $853.615M Est
Benzinga Newsdesk 9 hours ago
NewsGuidance
Inspire Medical Systems (NYSE:INSP) narrows FY2026 Adj EPS guidance from $1.05-$1.45 to $1.20-$1.40 vs $1.25 analyst estimate. Narrows FY2026 sales outlook from $835.000 million-$875.000 million to $850.000
Inspire Medical Systems (NYSE:INSP) narrows FY2026 Adj EPS guidance from $1.05-$1.45 to $1.20-$1.40 vs $1.25 analyst estimate. Narrows FY2026 sales outlook from $835.000 million-$875.000 million to $850.000 million-$860.000 million vs $853.615 million estimate.